MapLight dims preclinical programs to make phase 3-ready schizophrenia drug shine brighter Read more 

PDS halts work on phase 3 cancer therapy to focus on colorectal contender Read more 

After tasting IPO success, Hemab’s CEO seeks ‘flavor of a multi-product coagulation company’ Read more 

About Charles Muriuki

This author has not yet filled in any details.
So far Charles Muriuki has created 2 blog entries.
Go to Top